Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Functional Remission Occurrence and Predictive Factors in Schizophrenia

NCT02874560 is registered in ClinicalTrials.gov with Janssen-Cilag Ltd. as lead sponsor.

NCT NCT02874560
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02874560 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Functional Remission Occurrence and Predictive Factors in Schizophrenia
Lead sponsor
Janssen-Cilag Ltd.
Phase
Observational
Overall status
Completed
Start date
August 12, 2014
Completion date
July 12, 2017
Enrollment
364 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia